rs141743580
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM2BP4_StrongBP6_Very_StrongBS1
The NM_194318.4(B3GLCT):c.450C>A(p.Asp150Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000193 in 1,568,228 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_194318.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
B3GLCT | NM_194318.4 | c.450C>A | p.Asp150Glu | missense_variant | 6/15 | ENST00000343307.5 | NP_919299.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
B3GLCT | ENST00000343307.5 | c.450C>A | p.Asp150Glu | missense_variant | 6/15 | 1 | NM_194318.4 | ENSP00000343002.4 |
Frequencies
GnomAD3 genomes AF: 0.00109 AC: 166AN: 152152Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000287 AC: 72AN: 251008Hom.: 0 AF XY: 0.000169 AC XY: 23AN XY: 135722
GnomAD4 exome AF: 0.0000968 AC: 137AN: 1415958Hom.: 0 Cov.: 24 AF XY: 0.0000792 AC XY: 56AN XY: 707338
GnomAD4 genome AF: 0.00109 AC: 166AN: 152270Hom.: 1 Cov.: 33 AF XY: 0.00103 AC XY: 77AN XY: 74472
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital | Sep 05, 2017 | BS1, BS2, BP4; This alteration has an allele frequency that is greater than expected for the associated disease, was seen in a healthy adult where full penetrance of the disorder is expected at an early age, and is predicted to be tolerated by multiple functional prediction tools. - |
Peters plus syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 28, 2021 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at